Search clinical trials for: Raxibacumab

Total 3 results

Human Genome Sciences Inc.
GlaxoSmithKline; Emergent BioSolutions

Completed

An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

Therapeutic Treatment of Inhalation Anthrax
Human Genome Sciences Inc.
GlaxoSmithKline; Emergent BioSolutions

Completed

A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects

Healthy
Emergent BioSolutions
GlaxoSmithKline

Completed

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Infections, Bacterial

United States

3

Subscribe